Expand the reach of your studies and find the right population using our global experience to help inform your portfolio and feasibility decisions.
Leverage our unique view of the world using our established resources in Africa, Asia, Europe, Latin America and North America.
The boundaries and names on this map do not imply official endorsement or acceptance by FHI Clinical.
We’ve been involved in observational studies, behavioral studies and clinical trials for epidemiology, spatial repellents, vaccines and treatments in 32 African countries.
FHI Clinical offices and 361 staff members are located in 7 countries throughout Africa.
Our research involvement has included a range of non-communicable diseases as well as infectious diseases.
We’ve been involved in observational and clinical trials for epidemiology, diagnostic tests, vaccines and disease treatment in 14 Asia Pacific countries.
FHI Clinical offices and resources are located in three countries throughout Asia Pacific.
Our research involvement has included acute respiratory infection, COVID-19, dengue, diabetes, HIV, HPV, influenza, Japanese encephalitis, lymphatic filariasis, malaria, melioidosis, oncology, polyvalent vaccines, rotavirus gastroenteritis, sepsis and tuberculosis.
We’ve been involved in observational, epidemiological and clinical trials for diagnostic tests, vaccines and treatments in 12 European countries.
FHI Clinical has staff located in the United Kingdom.
Our research involvement has included studies for COVID-19, HIV, hormone replacement therapy (HRT), malaria and tuberculosis.
We’ve been involved in clinical trials for vaccines and treatments for diseases in 12 Latin American and Caribbean countries.
FHI Clinical has a resource located in Peru.
Our involvement in clinical trials has included Chikungunya, COVID-19, HIV, malaria, tuberculosis and Zika.
We’ve been involved in clinical trials for vaccines and therapeutics in the majority of the United States as well as Mexico.
FHI Clinical offices and resources are located in 17 locations throughout North America, including our headquarters in Durham, NC.
Our research involvement has included asthma, COVID-19, genital herpes, HIV, malaria, Nipah virus and Zika.
Our far-reaching, in-country technical, regulatory and cultural knowledge has been developed over our long history of working in sub-Saharan Africa.
We’ve supported first-in-human to phase 4 clinical trials as well as epidemiological, observational and bioequivalence studies for pediatric and adult populations.
Data current as of July 1, 2023. The boundaries and names on this map do not imply official endorsement or acceptance by FHI Clinical.
Our database includes 432 research-ready sites across 30 countries, with experience spanning all clinical trial phases, infectious and non-communicable diseases as well as pediatric and adult populations.
Data current as of July 1, 2023. The boundaries and names on this map do not imply official endorsement or acceptance by FHI Clinical.
We are committed to improving public health through responsive, inclusive, and scalable clinical research solutions in Africa.
Have questions or need more information? Reach out to our team—we’re here to help and eager to connect.
"*" indicates required fields
We envision a world where advances in vaccines and medicines help all people live longer, healthier lives.
359 Blackwell Street, Suite 200, Durham, NC 27701 USA
Britam Towers, 24th Floor, Hospital Road, Upper Hill KENYA
3A Cinsaut House Dorpstreet, The Vinevard Office Estate, Bellville, Western Cape, 7530, South Africa
The Cape Hotel, Mamba Point, Monrovia LIBERIA
Camino Real a Tetelpan #207, Colonia Tetelpan, Delegación Alvaro Obregon, Ciudad México, CP 01700, Mexico
